228 related articles for article (PubMed ID: 19417741)
1. Sleeping beauty transposition from nonintegrating lentivirus.
Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
[TBL] [Abstract][Full Text] [Related]
2. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
[TBL] [Abstract][Full Text] [Related]
4. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
5. An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.
Benati D; Cocchiarella F; Recchia A
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364270
[TBL] [Abstract][Full Text] [Related]
6. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
Izsvák Z; Ivics Z; Plasterk RH
J Mol Biol; 2000 Sep; 302(1):93-102. PubMed ID: 10964563
[TBL] [Abstract][Full Text] [Related]
7. Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Federoff HJ; Bowers WJ
Gene Ther; 2010 Mar; 17(3):424-31. PubMed ID: 19865178
[TBL] [Abstract][Full Text] [Related]
8. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
9. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
10. Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase.
Tschorn N; van Heuvel Y; Stitz J
Mol Biotechnol; 2023 Aug; 65(8):1327-1335. PubMed ID: 36547824
[TBL] [Abstract][Full Text] [Related]
11. Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors.
Moldt B; Yant SR; Andersen PR; Kay MA; Mikkelsen JG
Hum Gene Ther; 2007 Dec; 18(12):1193-204. PubMed ID: 17988194
[TBL] [Abstract][Full Text] [Related]
12. RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration.
Rauschhuber C; Ehrhardt A
PLoS One; 2012; 7(5):e35389. PubMed ID: 22570690
[TBL] [Abstract][Full Text] [Related]
13. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
14. Integrase-defective lentiviral vectors--a stage for nonviral integration machineries.
Staunstrup NH; Mikkelsen JG
Curr Gene Ther; 2011 Oct; 11(5):350-62. PubMed ID: 21745178
[TBL] [Abstract][Full Text] [Related]
15. The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition.
Zayed H; Izsvák Z; Khare D; Heinemann U; Ivics Z
Nucleic Acids Res; 2003 May; 31(9):2313-22. PubMed ID: 12711676
[TBL] [Abstract][Full Text] [Related]
16. Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.
Zhang W; Muck-Hausl M; Wang J; Sun C; Gebbing M; Miskey C; Ivics Z; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e75344. PubMed ID: 24124483
[TBL] [Abstract][Full Text] [Related]
17. Development of hyperactive sleeping beauty transposon vectors by mutational analysis.
Zayed H; Izsvák Z; Walisko O; Ivics Z
Mol Ther; 2004 Feb; 9(2):292-304. PubMed ID: 14759813
[TBL] [Abstract][Full Text] [Related]
18. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Izsvák Z; Ivics Z; Bowers WJ
Hum Gene Ther; 2010 Nov; 21(11):1603-13. PubMed ID: 20507234
[TBL] [Abstract][Full Text] [Related]
20. High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene.
Zhu J; Park CW; Sjeklocha L; Kren BT; Steer CJ
Biochemistry; 2010 Feb; 49(7):1507-21. PubMed ID: 20041635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
